Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹457 Cr₹489 Cr₹90 Cr₹94 Cr₹80 Cr

What is the latest Total Non-Current Liabilities ratio of GLAND PHARMA ?

The latest Total Non-Current Liabilities ratio of GLAND PHARMA is ₹457 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹457 Cr
Mar2024₹489 Cr
Mar2023₹90 Cr
Mar2022₹94 Cr
Mar2021₹80 Cr

How is Total Non-Current Liabilities of GLAND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹457 Cr
-6.41
Mar2024 ₹489 Cr
444.83
Mar2023 ₹90 Cr
-4.57
Mar2022 ₹94 Cr
17.01
Mar2021 ₹80 Cr -

Compare Total Non-Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹38,176.1 Cr 5.3% 0.3% 36.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹446,792.0 Cr 1.4% 1.2% 13.8% Stock Analytics
DIVIS LABORATORIES ₹178,152.0 Cr -0.5% -0.6% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹152,915.0 Cr 2.1% 1.5% 42.2% Stock Analytics
CIPLA ₹116,354.0 Cr 6.4% 1.6% -3.1% Stock Analytics
DR REDDYS LABORATORIES ₹112,681.0 Cr 6.2% 1.6% 0.2% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

5.3%

0.3%

36.1%

SENSEX

-0.4%

0.8%

-5.3%


You may also like the below Video Courses